| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |